Genomic and Epigenomic Profile of Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMPs) Revealed Similarities and Differences with Leiomyomas and Leiomyosarcomas.

International Journal of Molecular Sciences
Donatella ConconiAngela Bentivegna


Uterine smooth muscle tumors of uncertain malignant potential (STUMPs) represent a heterogeneous group of tumors that cannot be histologically diagnosed as unequivocally benign or malignant. For this reason, many authors are working to obtain a better definition of diagnostic and prognostic criteria. In this work, we analyzed the genomic and epigenomic profile of uterine smooth muscle tumors (USMTs) in order to find similarities and differences between STUMPs, leiomyosarcomas (LMSs) and leiomyomas (LMs), and possibly identify prognostic factors in this group of tumors. Array-CGH data on 23 USMTs demonstrated the presence of a more similar genomic profile between STUMPs and LMSs. Some genes, such as PRKDC and PUM2, with a potential prognostic value, were never previously associated with STUMP. The methylation data appears to be very promising, especially with regards to the divergent profile found in the sample that relapsed, characterized by an overall CGI hypomethylation. Finally, the Gene Ontology analysis highlighted some cancer genes that could play a pivotal role in the unexpected aggressive behavior that can be found in some of these tumors. These genes could prove to be prognostic markers in the future.


Apr 19, 2003·Science·François GaudetRudolf Jaenisch
Feb 14, 2004·Bioinformatics·Tim Beissbarth, Terence P Speed
Apr 12, 2005·Annual Review of Pharmacology and Toxicology·Manel Esteller
Jun 17, 2005·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Michèle J Hoffmann, Wolfgang A Schulz
Nov 3, 2005·Oncology Research·Thilo LanerAndrea R Florl
Jul 4, 2007·American Journal of Medical Genetics. Part a·Sau W CheungV Reid Sutton
Apr 21, 2009·Nature Structural & Molecular Biology·Ravid StraussmanHoward Cedar
May 7, 2009·The American Journal of Surgical Pathology·Philip P C IpPhilip B Clement
Mar 8, 2013·PloS One·Simona BaronchelliLeda Dalprà
Dec 7, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Liam CornellHelen L Reeves
Dec 23, 2016·Oncology Reports·Donatella ConconiAndrea Alberto Lissoni
Jul 22, 2017·Biochemical and Biophysical Research Communications·Yejun LiuChenghong Zhang
Jan 13, 2018·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Sabrina CroceFrédéric Chibon
Jun 15, 2018·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Hyeong In HaChan Lee
Feb 13, 2019·Cancer Cell·Lu Wang, Ali Shilatifard
Feb 23, 2019·Cell Structure and Function·Yuanyu WangBaohua Jiao
Feb 24, 2019·Cancer Letters·Olja MijanovićMaciej S Lesniak
Mar 26, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Lansheng ZhangZhengxiang Han
Jul 22, 2019·Gynecologic Oncology·Angiolo Gadducci, Gian Franco Zannoni
Aug 10, 2019·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Kuo-Hao HoKu-Chung Chen
Oct 13, 2019·Seminars in Cancer Biology·Yannick VerhoevenPeter A van Dam
May 26, 2020·International Review of Neurobiology·Valeriy ShevchenkoIgor Bryukhovetskiy

❮ Previous
Next ❯

Methods Mentioned

Feature Extraction

Software Mentioned

Feature Extraction
Agilent Genomic Workbench
Agilent Feature Extraction

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.